Posted On: 09/02/2014 9:16:28 AM
Post# of 30066
Reki,
Welcome. Personally, I never expected upfront cash for the CLIA partnership. That will come from a JV partnership for the FDA approval process for LymPro.
This gets that ball rolling and shows prospective FDA approval partners that the LymPro ship is sailing so get something done. Revenue guidance today will be interesting as we now have a world wide lab, rather than only beginning in the US. The call will be enlightening.
I am interested in hearing about the MANF ODD that GC mentioned we expect by end of summer or right before the shareholder's meeting.
Welcome. Personally, I never expected upfront cash for the CLIA partnership. That will come from a JV partnership for the FDA approval process for LymPro.
This gets that ball rolling and shows prospective FDA approval partners that the LymPro ship is sailing so get something done. Revenue guidance today will be interesting as we now have a world wide lab, rather than only beginning in the US. The call will be enlightening.
I am interested in hearing about the MANF ODD that GC mentioned we expect by end of summer or right before the shareholder's meeting.
(0)
(0)
